TerrAscend Corp. (TSND) Earnings Call Transcripts

36 earnings calls from April 2020 to August 6, 2026

TSX CA Health Care Pharmaceuticals

TerrAscend Corp.'s Latest Earnings Call - June 9, 2026

The TerrAscend Corp. (TSND:CA) 2026 Annual Meeting focused on the election of directors, ratification of auditors, and approval of stock and RSU plans. The meeting did not provide specific financial results or forward-looking guidance, which may leave investors seeking more information on the company's financial health and strategic direction. All proposed resolutions were passed with requisite shareholder approval, indicating strong support for management's proposals.

Reported metrics

MetricValueContext
Director Elections 5 directors elected (inline) Uncontested elections, approved by shareholders
Auditor Ratification MNP LLP ratified (inline) No objections or questions raised
Stock Option Plan Approval Plan approved (inline) In accordance with TSX rules
RSU Plan Approval Plan approved (inline) In accordance with TSX rules

What management said

I nominate each of the persons specified in Management Information Circular delivered with the Notice of Meeting, namely: Mr. Craig Collard, Ms. Kara DioGuardi, Ms. Ira Duarte, Mr. Ed Schutter and Mr. Jason Wild, to serve as directors of the corporation and to hold office until the close of the next Annual Meeting of Shareholders of the corporation or any postponement or adjournment thereof unless their offices are v...
— Unknown Executive, June 9, 2026 earnings call
As the corporation did not previously receive timely notice of any further nominations of persons for election as directors of the corporation as required by the advanced notice provisions of the corporation's bylaws, I declare the nominations closed. In order that a vote may be held on this matter, I request a motion that the 5 persons nominated as directors of the corporation be so elected.
— Jason Wild, June 9, 2026 earnings call

What analysts pressed on

The meeting did not address specific financial performance or future guidance, which may leave analysts concerned about the company's strategic direction and financial outlook. The lack of detailed financial discussion could be a point of concern for those seeking more transparency.

Main topics on the call

Read the full TerrAscend Corp. transcript (June 9, 2026) → Summary generated from the call transcript; every figure above is stated by management on the record.

About TerrAscend Corp.

TerrAscend Corp. (TSND) is a publicly listed company in the Pharmaceuticals industry, within the Health Care sector. It trades on TSX and is based in CA. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 36 calls on record spanning April 24, 2020 to August 6, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.

Earnings Call History

EarningsCalls.dev has 36 TerrAscend Corp. earnings call transcripts on record, spanning April 24, 2020 to August 6, 2026. Based on this history, TerrAscend Corp. reports quarterly. The most recent call on file is dated August 6, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker
TSND
Exchange
TSX
Country
CA
Sector
Health Care
Industry
Pharmaceuticals
Calls on record
36
First call
April 24, 2020
Most recent
August 6, 2026
Reporting cadence
quarterly
Quarter Date
Q2 FY2026 Aug 6, 2026 Read transcript
Shareholder/Analyst Calls Jun 9, 2026 Read transcript
Q1 FY2026 May 7, 2026 Read transcript
Q4 FY2025 Mar 12, 2026 Read transcript
Shareholder/Analyst Calls Jun 24, 2025 Read transcript
Q1 FY2025 May 8, 2025 Read transcript
Q4 FY2024 Mar 6, 2025 Read transcript
Q3 FY2024 Nov 6, 2024 Read transcript
Q2 FY2024 Aug 8, 2024 Read transcript
Shareholder/Analyst Calls Jun 17, 2024 Read transcript
Q1 FY2024 May 9, 2024 Read transcript
Earnings Calls Mar 14, 2024 Read transcript
Q3 FY2023 Nov 9, 2023 Read transcript
Analyst/Investor Day Oct 13, 2023 Read transcript
Q2 FY2023 Aug 10, 2023 Read transcript
Shareholder/Analyst Calls Jun 22, 2023 Read transcript
Q1 FY2023 May 11, 2023 Read transcript
Q4 FY2022 Mar 16, 2023 Read transcript
Q3 FY2022 Nov 14, 2022 Read transcript
Q2 FY2022 Aug 11, 2022 Read transcript
Shareholder/Analyst Calls Jun 27, 2022 Read transcript
Q1 FY2022 May 12, 2022 Read transcript
Q4 FY2021 Mar 16, 2022 Read transcript
Q3 FY2021 Nov 16, 2021 Read transcript
Q2 FY2021 Aug 19, 2021 Read transcript
Shareholder/Analyst Calls Jun 28, 2021 Read transcript
Q1 FY2021 May 19, 2021 Read transcript
Q4 FY2020 Mar 23, 2021 Read transcript
Company Conference Presentations Mar 16, 2021 Read transcript
Company Conference Presentations Nov 30, 2020 Read transcript
Q3 FY2020 Nov 19, 2020 Read transcript
Q2 FY2020 Aug 20, 2020 Read transcript
Shareholder/Analyst Calls Aug 18, 2020 Read transcript
Analyst/Investor Day Aug 6, 2020 Read transcript
Q1 FY2020 May 29, 2020 Read transcript
Earnings Calls Apr 24, 2020 Read transcript